Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
996
JPY
|
-0.50%
|
|
-0.30%
|
-6.39%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
14,244
|
10,770
|
10,251
|
10,440
|
10,156
|
9,842
|
Enterprise Value (EV)
1 |
8,262
|
5,558
|
5,049
|
3,955
|
2,310
|
1,237
|
P/E ratio
|
16.6
x
|
10.8
x
|
12
x
|
19.2
x
|
12.4
x
|
11.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.37
x
|
0.27
x
|
0.23
x
|
0.25
x
|
0.22
x
|
0.21
x
|
EV / Revenue
|
0.22
x
|
0.14
x
|
0.11
x
|
0.1
x
|
0.05
x
|
0.03
x
|
EV / EBITDA
|
5.48
x
|
3.81
x
|
3.62
x
|
3.2
x
|
1.43
x
|
0.71
x
|
EV / FCF
|
9.83
x
|
30.9
x
|
8
x
|
2.77
x
|
1.37
x
|
1
x
|
FCF Yield
|
10.2%
|
3.23%
|
12.5%
|
36.1%
|
73.1%
|
100%
|
Price to Book
|
1.93
x
|
1.39
x
|
1.24
x
|
1.39
x
|
1.25
x
|
1.12
x
|
Nbr of stocks (in thousands)
|
11,278
|
11,277
|
11,277
|
9,803
|
9,803
|
9,803
|
Reference price
2 |
1,263
|
955.0
|
909.0
|
1,065
|
1,036
|
1,004
|
Announcement Date
|
6/28/18
|
6/27/19
|
6/25/20
|
6/28/21
|
6/29/22
|
6/28/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
38,275
|
40,380
|
44,653
|
41,007
|
45,496
|
47,483
|
EBITDA
1 |
1,508
|
1,458
|
1,396
|
1,234
|
1,618
|
1,731
|
EBIT
1 |
1,334
|
1,238
|
1,114
|
848
|
1,252
|
1,340
|
Operating Margin
|
3.49%
|
3.07%
|
2.49%
|
2.07%
|
2.75%
|
2.82%
|
Earnings before Tax (EBT)
1 |
1,225
|
1,347
|
1,096
|
845
|
1,258
|
1,350
|
Net income
1 |
856
|
974
|
792
|
572
|
863
|
936
|
Net margin
|
2.24%
|
2.41%
|
1.77%
|
1.39%
|
1.9%
|
1.97%
|
EPS
2 |
75.90
|
88.45
|
75.56
|
55.50
|
83.33
|
90.04
|
Free Cash Flow
1 |
840.8
|
179.8
|
631.2
|
1,429
|
1,688
|
1,238
|
FCF margin
|
2.2%
|
0.45%
|
1.41%
|
3.48%
|
3.71%
|
2.61%
|
FCF Conversion (EBITDA)
|
55.75%
|
12.33%
|
45.22%
|
115.8%
|
104.3%
|
71.49%
|
FCF Conversion (Net income)
|
98.22%
|
18.45%
|
79.7%
|
249.83%
|
195.54%
|
132.21%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/28/18
|
6/27/19
|
6/25/20
|
6/28/21
|
6/29/22
|
6/28/23
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
22,121
|
19,310
|
22,032
|
11,969
|
11,773
|
23,618
|
11,917
|
11,604
|
22,632
|
11,611
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
446
|
245
|
522
|
418
|
208
|
598
|
349
|
191
|
323
|
127
|
Operating Margin
|
2.02%
|
1.27%
|
2.37%
|
3.49%
|
1.77%
|
2.53%
|
2.93%
|
1.65%
|
1.43%
|
1.09%
|
Earnings before Tax (EBT)
1 |
454
|
243
|
524
|
420
|
214
|
612
|
345
|
194
|
337
|
-170
|
Net income
1 |
314
|
162
|
359
|
290
|
149
|
416
|
236
|
131
|
233
|
-119
|
Net margin
|
1.42%
|
0.84%
|
1.63%
|
2.42%
|
1.27%
|
1.76%
|
1.98%
|
1.13%
|
1.03%
|
-1.02%
|
EPS
2 |
29.39
|
15.84
|
34.89
|
28.03
|
14.48
|
40.19
|
22.73
|
12.68
|
22.39
|
-11.45
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/30/19
|
10/30/20
|
11/1/21
|
1/31/22
|
8/1/22
|
10/31/22
|
1/31/23
|
7/31/23
|
10/31/23
|
1/31/24
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
5,982
|
5,212
|
5,202
|
6,485
|
7,846
|
8,605
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
841
|
180
|
631
|
1,429
|
1,688
|
1,238
|
ROE (net income / shareholders' equity)
|
12.1%
|
13.1%
|
10.5%
|
7.39%
|
10.5%
|
10.5%
|
ROA (Net income/ Total Assets)
|
4.9%
|
4.27%
|
3.57%
|
2.59%
|
3.66%
|
3.66%
|
Assets
1 |
17,459
|
22,827
|
22,185
|
22,090
|
23,590
|
25,593
|
Book Value Per Share
2 |
654.0
|
689.0
|
736.0
|
769.0
|
830.0
|
896.0
|
Cash Flow per Share
2 |
540.0
|
489.0
|
509.0
|
630.0
|
758.0
|
829.0
|
Capex
1 |
271
|
173
|
368
|
248
|
111
|
229
|
Capex / Sales
|
0.71%
|
0.43%
|
0.82%
|
0.6%
|
0.24%
|
0.48%
|
Announcement Date
|
6/28/18
|
6/27/19
|
6/25/20
|
6/28/21
|
6/29/22
|
6/28/23
|
|
1st Jan change
|
Capi.
|
---|
| -6.39% | 62.02M | | -3.41% | 9.4B | | +30.20% | 1.92B | | -3.90% | 1.39B | | -7.38% | 1.18B | | -18.42% | 856M | | +0.48% | 470M | | +3.62% | 437M | | -48.57% | 360M | | -24.72% | 333M |
Medical Equipment Wholesale
|